Conference abstract · 25 Apr 2019
Conference abstractPublished 2 Nov 2017
Cationic pDNA vaccines for immuno-contraception and rabies control
Mercer University, USA; The Centers for Disease Control and Prevention, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Plasmid DNA (pDNA) vaccines have the potential to elicit an immune response against a wide range of diseases. However, the limitation of poor uptake of pDNA to antigen-presenting cells and rapid degradation of pDNA encapsulated in nanoparticles prompted us to fabricate an encapsulation free pDNA nanoparticulate vaccine. The negatively charge pDNA adsorbs on cationic PLGA (poly (d, l-lactide-co-glycolide)-chitosan nanoparticles and were used as means to deliver pDNA. Nanoparticles in the size range of 380-500 nm with a zeta potential of 50.0 mV were prepared using emulsification method. pDNA PLGA-chitosan nanoparticles were dispersed in poloxamer 407 that possess fluid property at 4oC and turns into gel at body temperature. Binding affinity of pDNA to cationic nanoparticles depends on pDNA to nanoparticles ratio (P/N) and complete immobilization of pDNA to cationic nanoparticles was achieved at a P/N ratio of 1/50. pDNA adsorption efficiency of 99.0 percent was achieved in pDNA PLGAchitosan nanoparticles prepared using chitosan glutamate concentration of 2 mg/mL. Complex of pDNA and cationic nanoparticles was well tolerated and maintained cell survival rate greater than 80.0 percent. Additionally, cellular uptake was found to be both time and concentration dependent and followed saturation kinetics with Vmax of 11.389 Ã?µg/mL.hr and Km value of 139.48 Ã?µg/mL. In-vitro release study of P/N, 1/50 showed that the nanoparticulate vaccine can sustain the release of pDNA up to 24 hours. In our study, we demonstrated that pDNA PLGA-chitosan nanoparticles were non-cytotoxic, showed enhance cellular uptake, and sustain the release of pDNA for extended period.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2 Jul 2018
Non-surgical contraception in feral cats: Short term efficacy and safety of combined vaccination with anti-GnRH (GonaCon) and rabies vaccines
Conference abstract · 28 Jan 2022
Outer Membrane Proteins of Salmonella Typhimurium as an Adjuvant in Rabies Vaccine
Conference abstract · 30 Aug 2021
Application of the theory of planned behavior to vaccination of dogs against rabies in Abeokuta Ogun State, Nigeria
Conference abstract · 6 Dec 2018
Application of the theory of planned behaviour to vaccination of dogs against rabies in Abeokuta Ogun State, Nigeria
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Perspective · 10 Sep 2026
Cellular Pathways Involved in Mucosal Immunity and Protection Against Environmental Challenges
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Amit Bansal”
- BylineArticles whose byline prints “Xianfu Wu”
- BylineArticles whose byline prints “Martin J D’Souza”

